ISRCTN14635089
Active, not recruiting
未知
Clinical application of whole genome sequencing in multidrug-resistant tuberculosis patients in Tanzania
Tanzania Commission for Science and Technology0 sites153 target enrollmentMarch 6, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Application of whole genome sequencing in multidrug resistance tuberculosis patients
- Sponsor
- Tanzania Commission for Science and Technology
- Enrollment
- 153
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. TB patients aged \=18 years
- •2\. Confirmed either as MDR\-TB or non MDRTB using DST, Xpert® MTB/RIF assay GeneXpert® (Cepheid, Sunnyvale, CA, USA), GenoType MTBDRplus (Hain Life science, GmbH, Nehren)
- •3\. Willingness to sign a written informed consent and provide sputum samples for laboratory analysis.
Exclusion Criteria
- •Does not meet inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Whole genome analysis in patients with resected non-small cell lung cancer (WJOG16622L)JPRN-UMIN000050729West Japan Oncology Group200
Not yet recruiting
Not Applicable
Whole Exome & Whole Genome Sequencing Analysis to Explore Familial Keratoconuseye bulging10002693NL-OMON53921Erasmus MC, Universitair Medisch Centrum Rotterdam
Completed
Not Applicable
Prospective clinical study of comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer.advanced cancerJPRN-UMIN000042408Kyoto University Hospital182
Completed
Not Applicable
Clinical utility of rapid genome sequencing in critically ill children in GermanyDRKS00025163Institut für Humangenetik130
Not yet recruiting
Not Applicable
Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCChepatocellular carcinomaJPRN-UMIN000032493Kyoto University600